Functional Endoscopic Sinus Surgery Market is expected to hit USD 1.91B by 2032, at CAGR of 7.66%.

The high prevalence of chronic sinusitis is driving the demand for functional endoscopic sinus surgery market. Chronic rhinosinusitis affects approximately 20% of CRS patients. This renders nasal polyps a very concerning and relevant predisposition to sinusitis. However, the problem is more than just medical, and nasal polyps are one of the most relevant economic drivers of the disease. The cost of CRS is very high due to the relevant prevalence of the disease. Around one in eight people have CRS, and it is one of the prime reasons for visits to a physician. The direct cost to the United States for CRS amounts to ten to thirteen billion dollars per year. The indirect costs are even higher due to the lost productivity, amounting to over twenty billion dollars. The disease needs to be addressed, and chronic sinusitis, in particular, can be a perplexing problem that requires intense treatment, including multiple medications, a lifestyle change, and sometimes even surgical interventions. Overall, chronic sinusitis is a problem that may be troubling both to the patient and from a global public health perspective. It is one of the leading reasons for physician visits and associated high associated costs, only a portion of which is directly related to healthcare.